Gil Carrasquinho

Gil Carrasquinho has a diverse work experience in the pharmaceutical industry. Starting in 2006, they founded and was the managing partner of Solidlink Consulting for five years. Gil then joined Novartis in 2012 as a Clinical Manager, later becoming a Senior Medical Scientific Expert and Regional Medical Director in the Asia Pacific and Middle East regions. In 2015, Gil joined Santen as the Director of Medical Affairs and MSL Team Europe before being promoted to other roles such as Vice President of Medical Affairs EMEA and Vice President of Advisory Global Corporate Development Division. Currently, they hold the position of VP Global Head of Strategy, Operations, and Assets Cell and Gene BU at Santen.

Gil Carrasquinho holds a Doctor of Medicine (M.D.) degree in General medicine from Semmelweis University. Gil also has a Master of Business Administration (M.B.A.) degree with a focus on GEMBA from INSEAD. Additionally, Gil has a Diploma in European Market Access from Université Claude Bernard Lyon 1, and a Post-Graduate Diploma in Pharmaceutical Medicine & Medicines Development Sciences from Université libre de Bruxelles. Gil has obtained a Diploma in Venture Finance from Saïd Business School, University of Oxford. Gil has also completed the Stanford Advanced Project Management Certificate from Stanford University.